Abiomed Inc. v. Maquet Cardiovascular LLC, No. 24-1062 (Fed. Cir. Feb. 9, 2026)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Maquet Cardiovascular LLC (“Maquet”) appeals from a final judgment of the United States District Court for the District of Massachusetts, ordering that Abiomed Inc., Abi- omed Europe GmbH, and Abiomed R&D, Inc. (collectively, “Abiomed”) have not infringed any claim of U.S. Pat ent Nos. 7,022,100; 8,888,728; 9,327,068; 9,545,468; 9,561,314; and 9,597,437 (collectively, the “Asserted Patents” ). J.A. 1–2. For the reasons discussed below, we affirm-in- part , vacate-in-part , and remand . I.